Fonar Corporation is a medical - devices company in the healthcare sector trading on NASDAQ, led by CEO Timothy R. Damadian, with a market cap of $117.0M.
Upcoming earnings announcement for Fonar Corporation
Past 12 earnings reports for Fonar Corporation
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Feb 13, 2026 | Q2 2026 | $0.31 | — | $25.5M | — | |
| Nov 10, 2025 | Q1 2026 | $0.34 | — | $24.5M | — | |
| Sep 12, 2025 | Q4 2025 | $0.11 | — | $27.3M | — | |
| May 15, 2025 | Q3 2025 | $0.37 | — | $27.2M | — | |
| Feb 18, 2025 | Q2 2025 | $0.29 | — | $25.0M | — | |
| Nov 12, 2024 | Q1 2025 | $0.46 | — | $25.0M | — | |
| Sep 27, 2024 | Q4 2024 | $0.13 | — | $25.9M | — | |
| May 15, 2024 | Q3 2024 | $0.27 | — | $25.7M | — | |
| Feb 14, 2024 | Q2 2024 | $0.54 | — | $25.4M | — | |
| Nov 14, 2023 | Q1 2024 | $0.59 | — | $25.8M | — | — |
| Sep 28, 2023 | Q4 2023 | $0.16 | — | $25.8M | — | |
| May 15, 2023 | Q3 2023 | $0.55 | — | $25.4M | — | — |
We use cookies for analytics. See our Privacy and Cookie Policy.